The hypoxia‐inducible factor is stabilized in circulating hematopoietic stem cells under normoxic conditions

C. Piccoli,A. D’Aprile,M. Ripoli,R. Scrima,D. Boffoli,A. Tabilio,N. Capitanio

Published 2007 in FEBS Letters

ABSTRACT

The hypoxia‐inducible factor (HIF) transcriptional system enables cell adaptation to limited O2 availability, transducing this signal into patho‐physiological responses such as angiogenesis, erythropoiesis, vasomotor control, and altered energy metabolism, as well as cell survival decisions. However, other factors beyond hypoxia are known to activate this pleiotropic transcription factor. The aim of this study was to characterize HIF in human hematopoietic stem cells (HSCs) and evidence is provided that granulocyte colony stimulating factor‐mobilized CD34+‐ and CD133+‐HSCs express a stabilized cytoplasmic form of HIF‐1α under normoxic conditions. It is shown that HIF‐1α stabilization correlates with down‐regulation of the tumour suppressor von Hippel‐Lindau protein (pVHL) and is positively controlled by NADPH‐oxidase‐dependent production of reactive oxygen species, indicating a specific O2‐independent post‐transcriptional control of HIF in mobilized HSCs. This novel finding is discussed in the context of the proposed role of HIF as a mediator of progenitor cell recruitment to injured ischemic tissues and/or in the control of the maintenance of the undifferentiated state.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-46 of 46 references · Page 1 of 1

CITED BY

Showing 1-59 of 59 citing papers · Page 1 of 1